| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/14737175.5.1.69 |
| P698 | PubMed publication ID | 15853476 |
| P50 | author | Philip B. Mitchell | Q37393406 |
| Gin Malhi | Q89872646 | ||
| P2860 | cites work | Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up | Q28182929 |
| Suicide as an outcome for mental disorders. A meta-analysis | Q28244203 | ||
| Pramipexole for bipolar II depression: a placebo-controlled proof of concept study | Q28268655 | ||
| A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders | Q33927263 | ||
| Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression | Q33949128 | ||
| Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis | Q33964983 | ||
| The long-term course of rapid-cycling bipolar disorder | Q33968228 | ||
| Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials | Q33975437 | ||
| Lamotrigine: a review of its use in bipolar disorder | Q34228876 | ||
| Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression | Q34275783 | ||
| Determinants of functional outcome and healthcare costs in bipolar disorder: a high-intensity follow-up study | Q34340583 | ||
| Antidepressants for bipolar depression: a systematic review of randomized, controlled trials | Q34344394 | ||
| A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year | Q34531152 | ||
| Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group | Q34727272 | ||
| Bipolar depression: relationship between episode length and antidepressant treatment | Q35010936 | ||
| Bipolar depression: management options | Q35017636 | ||
| Bipolar disorders and suicidal behaviour | Q35024540 | ||
| Health care utilization and costs among privately insured patients with bipolar I disorder | Q35041602 | ||
| Suicidal behaviour in bipolar disorder: risk and prevention | Q35129379 | ||
| Pharmacotherapy of bipolar II disorder: a critical review of current evidence | Q35680377 | ||
| Psychological interventions in bipolar disorder: From wishful thinking to an evidence-based approach | Q35872071 | ||
| Bipolar depression: phenomenological overview and clinical characteristics | Q35947340 | ||
| Risk of Recurrence Following Discontinuation of Lithium Treatment in Bipolar Disorder | Q37152810 | ||
| Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment | Q37402290 | ||
| Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression | Q39410022 | ||
| Mood stabilizers in the prevention of recurrent affective disorders: a meta-analysis | Q40783243 | ||
| The place of anticonvulsant therapy in bipolar illness | Q41257728 | ||
| A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group | Q42626284 | ||
| Mood-stabilisers reduce the risk of developing antidepressant-induced maniform states in acute treatment of bipolar I depressed patients | Q43540822 | ||
| ECT in bipolar and unipolar depression: differences in speed of response | Q43595309 | ||
| A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder | Q44403599 | ||
| Maintenance efficacy of divalproex in the prevention of bipolar depression | Q44464135 | ||
| Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study | Q44495168 | ||
| Suicide risk in bipolar disorder during treatment with lithium and divalproex | Q44586528 | ||
| The addition of lithium to carbamazepine. Antidepressant efficacy in treatment-resistant depression | Q44674218 | ||
| Case report: Successful riluzole augmentation therapy in treatment-resistant bipolar depression following the development of rash with lamotrigine | Q44727578 | ||
| Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone | Q44824135 | ||
| A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. | Q45931601 | ||
| The long-term natural history of the weekly symptomatic status of bipolar I disorder | Q46317822 | ||
| Twelve-month prevalence and disability of DSM-IV bipolar disorder in an Australian general population survey. | Q51936318 | ||
| The epidemiology of DSM-III-R bipolar I disorder in a general population survey. | Q53357821 | ||
| Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison. | Q53884881 | ||
| Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. | Q53965654 | ||
| The Current Understanding of Lamotrigine as a Mood Stabilizer | Q56555018 | ||
| Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder | Q57244668 | ||
| A Randomized Trial on the Efficacy of Group Psychoeducation in the Prophylaxis of Recurrences in Bipolar Patients Whose Disease Is in Remission | Q57612892 | ||
| P433 | issue | 1 | |
| P921 | main subject | bipolar depression | Q56014658 |
| P304 | page(s) | 69-78 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders | Q15760319 |
| P1476 | title | Treatment of bipolar depression: focus on pharmacologic therapies | |
| P478 | volume | 5 |
| Q57244624 | Recent progress in the pharmacotherapy of bipolar disorder | cites work | P2860 |
Search more.